Structures by: Trilleras J.
Total: 70
N^4^-(Cyclohexyl)-N^4^-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
C12H18N6
Acta Crystallographica Section B (2008) 64, 5 610-622
a=11.2407(10)Å b=7.3654(5)Å c=15.8178(12)Å
α=90.00° β=106.005(7)° γ=90.00°
N^4^-Methyl-N^4^-phenyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
C12H12N6
Acta Crystallographica Section B (2008) 64, 5 610-622
a=10.6661(12)Å b=7.7279(9)Å c=14.359(2)Å
α=90.00° β=100.071(7)° γ=90.00°
2-[4-(6-Amino-1H-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]ethanol
C11H17N7O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=7.0297(9)Å b=13.859(3)Å c=25.766(6)Å
α=90.00° β=90.00° γ=90.00°
N^4^-(4-Methoxyphenyl)-N^4^-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine hemihydrate
2(C13H14N6O),H2O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=8.9516(5)Å b=12.0627(7)Å c=12.9053(7)Å
α=91.612(4)° β=92.065(3)° γ=95.259(5)°
N^4^-Benzyl-N^4^-phenylyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine monohydrate
C18H16N6,H2O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=10.1880(11)Å b=9.5136(10)Å c=33.695(4)Å
α=90.00° β=93.131(7)° γ=90.00°
C11H15ClN4O
C11H15ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=5.907(2)Å b=10.398(3)Å c=10.801(2)Å
α=110.86(3)° β=94.19(2)° γ=96.00(3)°
C9H13ClN4O
C9H13ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=11.328(3)Å b=8.0810(4)Å c=11.3849(12)Å
α=90.00° β=98.709(14)° γ=90.00°
C9H11ClN4O2
C9H11ClN4O2
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.3540(5)Å b=8.2910(13)Å c=17.276(3)Å
α=90.00° β=97.962(9)° γ=90.00°
C12H17ClN4O
C12H17ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=8.5722(6)Å b=8.7195(5)Å c=8.7681(7)Å
α=82.598(6)° β=82.701(5)° γ=88.645(5)°
C14H15ClN4O
C14H15ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.9897(5)Å b=8.0922(4)Å c=11.2786(7)Å
α=91.602(4)° β=107.220(5)° γ=91.776(5)°
C13H13ClN4O
C13H13ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=8.1811(12)Å b=8.8325(10)Å c=9.3356(6)Å
α=81.844(9)° β=82.015(10)° γ=73.041(7)°
C12H11ClN4O
C12H11ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.0568(7)Å b=8.211(2)Å c=10.565(3)Å
α=84.590(16)° β=82.363(14)° γ=78.687(14)°
C12H11ClN4O
C12H11ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=6.9938(6)Å b=7.9544(10)Å c=10.7507(14)Å
α=81.191(11)° β=82.469(12)° γ=87.333(10)°
C15H12ClN5O
C15H12ClN5O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.5716(7)Å b=16.6432(18)Å c=10.9450(7)Å
α=90.00° β=93.549(6)° γ=90.00°
C18H15ClN4O
C18H15ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=6.5520(11)Å b=11.1012(7)Å c=11.4111(4)Å
α=79.958(5)° β=84.802(9)° γ=77.009(9)°
C11H16ClN5O2
C11H16ClN5O2
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.2147(6)Å b=8.8563(10)Å c=10.2855(12)Å
α=84.856(10)° β=85.296(10)° γ=79.092(7)°
C10H13ClN4O
C10H13ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=14.4681(17)Å b=11.1378(17)Å c=7.4534(7)Å
α=90.00° β=116.535(7)° γ=90.00°
N^4^-Methyl-N^4^-(4-phenylmethyl)-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine monohydrate
C13H14N6,H2O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=16.5577(12)Å b=8.6833(3)Å c=18.4640(13)Å
α=90.00° β=90.00° γ=90.00°
N^4^-Ethyl-N^4^-phenyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine hemihydrate
C13H14N6,0.5(H2O)
Acta Crystallographica Section B (2008) 64, 5 610-622
a=17.642(3)Å b=18.278(3)Å c=8.3034(18)Å
α=90.00° β=103.512(17)° γ=90.00°
3-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)-1,5-di-2-thienylpentane-1,5-dione
C23H19ClN2O2S2
Acta Crystallographica Section E (2005) 61, 6 o1892-o1894
a=14.6729(5)Å b=17.8962(6)Å c=16.2619(3)Å
α=90.00° β=90.00° γ=90.00°
5-Chloro-3-methyl-1-phenyl-1H-pyrazole-4-carbaldehyde
C11H9ClN2O
Acta Crystallographica Section E (2005) 61, 4 o1055-o1057
a=6.5683(2)Å b=6.7921(2)Å c=22.4418(6)Å
α=90.00° β=94.206(2)° γ=90.00°
2,5-Bis(4-methylphenyl)-7-phenyl-6,7-dihydropyrazolo[1,5-a]pyrimidine- 3,6-dicarbaldehyde
C28H23N3O2
Acta Crystallographica Section E (2006) 62, 11 o4930-o4932
a=10.4688(3)Å b=22.3018(7)Å c=11.0754(4)Å
α=90.00° β=118.723(2)° γ=90.00°
6-(1H-indol-3-yl)-3-methyl-4-(4-methylphenyl)-1-phenyl-1H- pyrazolo[3,4-b]pyridine-5-carbonitrile
C29H21N5,C3H7NO
Acta Crystallographica Section C (2007) 63, 5 o287-o291
a=9.8060(3)Å b=10.1820(3)Å c=13.818(2)Å
α=97.035(6)° β=104.455(6)° γ=96.171(3)°
6-(1H-indol-3-yl)-3-methyl-4-(4-methoxyphenyl)-1-phenyl-1H- pyrazolo[3,4-b]pyridine-5-carbonitrile
C29H21N5O,C3H7NO
Acta Crystallographica Section C (2007) 63, 5 o287-o291
a=30.303(3)Å b=11.3490(16)Å c=20.344(3)Å
α=90.00° β=131.010(5)° γ=90.00°
6-(1H-indol-3-yl)-3-methyl-1-phenyl-4-(3,4,5-trimethoxyphenyl)-1H- pyrazolo[3,4-b]pyridine-5-carbonitrile
C31H25N5O3
Acta Crystallographica Section C (2007) 63, 5 o287-o291
a=8.8241(10)Å b=11.9901(9)Å c=12.9130(17)Å
α=99.372(9)° β=108.822(12)° γ=90.994(7)°
2-(4-Chlorophenyl)-5-(4-nitrophenyl)-4,7- dihydropyrazolo[1,5-<i>a</i>]pyrimidine-3,6-dicarbaldehyde
C20H13ClN4O4
Acta Crystallographica Section C (2008) 64, 6 o341-o343
a=23.943(5)Å b=13.445(2)Å c=12.336(5)Å
α=90.00° β=118.594(10)° γ=90.00°
10-Ethyl-4-oxo-2,3,4,10-tetrahydropyrimido[4,5-b]quinolin-2-iminium 4-toluenesulfonate
C13H13N4O,C7H7O3S
Acta Crystallographica Section C (2008) 64, 7 o382-o384
a=9.0213(7)Å b=20.2880(18)Å c=10.3932(6)Å
α=90.00° β=90.245(5)° γ=90.00°
6-Amino-3-methyluracil-5-carbaldehyde
C6H7N3O3
Acta Crystallographica Section C (2009) 65, 6 o281-o283
a=6.6749(4)Å b=5.0712(5)Å c=19.7422(4)Å
α=90.00° β=99.996(2)° γ=90.00°
<i>N</i>^4^-Methyl-<i>N</i>^4^-(2-methylphenyl)-1<i>H</i>-pyrazolo[3,4- <i>d</i>]pyrimidine-4,6-diamine--ethanol--hydrazine (1/0.865/0.135)
C13H14N6,0.865(C2H6O1),0.135(N2H4)
Acta Crystallographica Section C (2009) 65, 6 o293-o295
a=16.349(3)Å b=14.051(2)Å c=13.625(3)Å
α=90.00° β=99.308(18)° γ=90.00°
3-Methyl-7-(2-thienyl)pyrido[2,3-<i>d</i>]pyrimidine-2,4(1<i>H</i>,3<i>H</i>)- dione
C12H9N3O2S
Acta Crystallographica Section C (2009) 65, 6 o284-o286
a=12.1969(15)Å b=13.4010(13)Å c=6.6071(8)Å
α=90.00° β=92.134(11)° γ=90.00°
5-Amino-3-methyl-1-phenyl-1<i>H</i>-pyrazole-4-carbaldehyde hemihydrate
C11H11N3O1,0.5H2O
Acta Crystallographica Section C (2010) 66, 1 o47-o49
a=10.8346(14)Å b=7.4952(9)Å c=24.621(3)Å
α=90.00° β=90.00° γ=90.00°
(5<i>RS</i>)-5-(4-Methoxyphenyl)-2-(methylsulfanyl)benzo[<i>g</i>]pyrimido[4,5-<i>b</i>]quinoline-4,6,11(3<i>H</i>,5<i>H</i>,12<i>H</i>)-trione
C23H17N3O4S
Acta Crystallographica Section C (2014) 70, 1 50-54
a=11.020(3)Å b=12.138(5)Å c=23.139(5)Å
α=85.33(3)° β=79.56(2)° γ=74.33(3)°
2-amino-4,6-bis[N-methyl-N-(4-methylphenyl)amino]pyrimidine-5-carbaldehyde
C21H23N5O
Acta Crystallographica Section C (2007) 63, 11 o681-o684
a=8.6844(6)Å b=10.7807(19)Å c=10.8903(10)Å
α=69.998(14)° β=88.918(7)° γ=76.822(13)°
2-amino-4-(indolin-1-yl)-6-methoxypyrimidine-5-carbaldehyde
C14H14N4O2
Acta Crystallographica Section C (2007) 63, 11 o681-o684
a=8.2846(4)Å b=11.2710(4)Å c=15.0024(7)Å
α=108.983(4)° β=95.403(4)° γ=101.908(3)°
6-(4-bromophenyl)-3-methyl-1-phenyl-4,5-dihydro-1<i>H</i>- pyrazolo[3,4-<i>b</i>]pyridine
C19H16BrN3
Acta Crystallographica Section C (2010) 66, 4 o163-o167
a=7.51650(10)Å b=11.6572(3)Å c=17.6917(5)Å
α=90.00° β=92.701(2)° γ=90.00°
3-(4-nitrophenyl)-4-phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine
C18H12N4O2
Acta Crystallographica Section C (2010) 66, 4 o163-o167
a=7.04080(10)Å b=9.6360(3)Å c=11.1961(3)Å
α=84.9060(10)° β=89.177(2)° γ=81.012(2)°
(<i>E</i>)-2-(1,3-Benzothiazol-2-yl)-3-(4-fluorophenyl)acrylonitrile
C16H9FN2S
Acta Crystallographica Section C (2013) 69, 6 671-673
a=8.2432(12)Å b=13.327(3)Å c=11.6819(19)Å
α=90.00° β=99.743(11)° γ=90.00°
3-<i>tert</i>-butyl-7-(2,3-dimethoxybenzyl)-4',4'-dimethyl-1-phenyl-4,5,6,7- tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane- 2',6'-dione
C32H39N3O4
Acta Crystallographica Section C (2008) 64, 12 o665-o670
a=12.4683(15)Å b=10.2892(12)Å c=21.7635(16)Å
α=90.00° β=90.843(10)° γ=90.00°
3-<i>tert</i>-butyl-4',4'-dimethyl-7-(3,4-methylenedioxobenzyl)-1-phenyl- 4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'- cyclohexane-2',6'-dione
C31H35N3O4
Acta Crystallographica Section C (2008) 64, 12 o665-o670
a=9.2691(14)Å b=11.0898(11)Å c=12.802(2)Å
α=92.844(10)° β=95.185(12)° γ=91.070(11)°
3-<i>tert</i>-butyl-1-phenyl-7-(4-trifluoromethylbenzyl)-4,5,6,7-tetrahydro- 1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane-2',6'-dione
C29H30F3N3O2
Acta Crystallographica Section C (2008) 64, 12 o671-o674
a=11.9298(18)Å b=10.5678(10)Å c=19.614(2)Å
α=90.00° β=96.627(10)° γ=90.00°
3-<i>tert</i>-butyl-7-(4-methoxybenzyl)-1-phenyl-4,5,6,7-tetrahydro- 1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane-2',6'-dione
C29H33N3O3
Acta Crystallographica Section C (2008) 64, 12 o671-o674
a=9.1904(10)Å b=11.9402(14)Å c=22.2888(16)Å
α=90.00° β=97.287(9)° γ=90.00°
3-<i>tert</i>-Butyl-4',4'-dimethyl-7-(4-methylbenzyl)-1-phenyl-4,5,6,7- tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane- 2',6'-dione ethanol hemisolvate
C31H37N3O2,0.5C2H6O
Acta Crystallographica Section C (2008) 64, 12 o637-o642
a=27.281(5)Å b=10.6438(15)Å c=21.567(3)Å
α=90.00° β=122.082(12)° γ=90.00°
3-<i>tert</i>-Butyl-4',4'-dimethyl-1-phenyl-7-[4-(trifluoromethyl)benzyl]- 4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'- cyclohexane-2',6'-dione ethanol hemisolvate
C31H34F3N3O2,0.5C2H6O
Acta Crystallographica Section C (2008) 64, 12 o637-o642
a=10.3270(12)Å b=11.9970(14)Å c=12.427(3)Å
α=75.016(13)° β=70.059(11)° γ=84.481(9)°
3-<i>tert</i>-butyl-4',4'-dimethyl-1-phenyl-7-(3,4,5-trimethoxybenzyl)- 4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'- cyclohexane-2',6'-dione ethanol 0.67-solvate
C33H41N3O5,0.67(C2H6O)
Acta Crystallographica Section C (2008) 64, 12 o665-o670
a=13.5770(17)Å b=17.476(3)Å c=26.670(3)Å
α=90.00° β=90.00° γ=90.00°
3-<i>tert</i>-Butyl-7-(4-chlorobenzyl)-4',4'-dimethyl-1-phenyl-4,5,6,7- tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane- 2',6'-dione ethanol hemisolvate
C30H34ClN3O2,0.5C2H6O
Acta Crystallographica Section C (2008) 64, 12 o637-o642
a=27.419(4)Å b=10.5860(13)Å c=21.580(3)Å
α=90.00° β=122.625(11)° γ=90.00°
3-<i>tert</i>-Butyl-7-(4-bromobenzyl)-4',4'-dimethyl-1-phenyl-4,5,6,7- tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane- 2',6'-dione ethanol hemisolvate
C30H34BrN3O2,0.5C2H6O
Acta Crystallographica Section C (2008) 64, 12 o637-o642
a=27.4453(7)Å b=10.5519(8)Å c=21.715(2)Å
α=90.00° β=122.484(7)° γ=90.00°
1,3-dimethyl-7-(4-methylphenyl)pyrido[2,3-<i>d</i>]pyrimidine- 2,4(1<i>H</i>,3<i>H</i>)-dione
C16H15N3O2
Acta Crystallographica Section C (2009) 65, 4 o134-o139
a=6.9953(5)Å b=7.9221(7)Å c=12.5140(13)Å
α=93.466(4)° β=92.993(6)° γ=101.152(6)°
7-(biphenyl-4-yl)-1,3-dimethylpyrido[2,3-<i>d</i>]pyrimidine- 2,4(1<i>H</i>,3<i>H</i>)-dione
C21H17N3O2
Acta Crystallographica Section C (2009) 65, 4 o134-o139
a=7.2314(5)Å b=17.5834(18)Å c=12.4864(15)Å
α=90.00° β=97.782(8)° γ=90.00°
7-(4-fluorophenyl)-3-methylpyrido[2,3-<i>d</i>]pyrimidine- 2,4(1<i>H</i>,3<i>H</i>)-dione
C14H10FN3O2
Acta Crystallographica Section C (2009) 65, 4 o134-o139
a=6.7658(8)Å b=12.978(2)Å c=13.162(2)Å
α=90.00° β=90.00° γ=90.00°
C15H13N3O3
C15H13N3O3
Acta Crystallographica Section C (2009) 65, 4 o134-o139
a=6.6312(11)Å b=6.8121(15)Å c=27.653(7)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-1-[(5-Chloro-3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl)methylidene]-2-phenylhydrazine
C17H15ClN4
Acta Crystallographica Section C (2014) 70, 2 216-219
a=11.773(2)Å b=9.9525(18)Å c=13.760(3)Å
α=90.00° β=114.519(10)° γ=90.00°
2-amino-4-(piperidin-1-yl)-11<i>H</i>-pyrimido[4,5-<i>b</i>][1,5]benzodiazepin- 6-ium chloride monohydrate
C16H19N6,Cl,H2O
Acta Crystallographica Section C (2010) 66, 4 o154-o158
a=13.7831(14)Å b=7.5324(9)Å c=15.2987(12)Å
α=90.00° β=94.925(8)° γ=90.00°
2-amino-4-[methyl(2-methylphenyl)amino]-11<i>H</i>-pyrimido[4,5- <i>b</i>][1,5]benzodiazepin-6-ium chloride--benzene-1,2-diamine (1/1)
C19H19N6,Cl,C6H8N2
Acta Crystallographica Section C (2010) 66, 4 o154-o158
a=10.9559(13)Å b=11.2372(13)Å c=11.432(2)Å
α=102.894(12)° β=112.176(14)° γ=107.512(10)°
(<i>E</i>)-<i>N</i>^2^-{4-[(<i>E</i>)-2-(4-Chlorobenzoyl)ethenyl]-3-methyl- 1-phenyl-1<i>H</i>-pyrazol-5-yl}-<i>N</i>^1^,<i>N</i>^1^-dimethylformamidine
C22H21ClN4O
Acta Crystallographica Section C (2010) 66, 5 o245-o248
a=8.2228(3)Å b=8.3506(2)Å c=28.7043(10)Å
α=90.00° β=90.00° γ=90.00°
3-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)-1,5-diphenylpentane-1,5-dione
C27H23ClN2O2
Acta Crystallographica Section C (2006) 62, 8 o518-o520
a=15.2964(3)Å b=17.4366(2)Å c=16.8320(3)Å
α=90.00° β=90.00° γ=90.00°
2-[6-amino-3-methyl-2-(methylsulfanyl)-4-oxo-3,4-dihydropyrimidin- 5-ylcarbonyl]acetonitrile
C9H10N4O2S
Acta Crystallographica Section C (2008) 64, 3 o149-o154
a=6.6449(3)Å b=8.7262(3)Å c=9.4092(2)Å
α=76.390(3)° β=81.079(2)° γ=82.654(4)°
2-(6-amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5- ylcarbonyl)acetonitrile
C9H10N4O3
Acta Crystallographica Section C (2008) 64, 3 o149-o154
a=22.488(3)Å b=5.0709(5)Å c=18.6139(17)Å
α=90.00° β=116.956(7)° γ=90.00°
2-cyano-<i>N</i>-[6-chloro-2-(methylsulfanyl)pyrimidin-4-yl]acetamide
C8H7ClN4OS
Acta Crystallographica Section C (2008) 64, 3 o149-o154
a=12.8655(7)Å b=8.4390(2)Å c=9.9327(15)Å
α=90.00° β=108.827(13)° γ=90.00°
2-cyano-<i>N</i>-[6-methoxy-2-(methylsulfanyl)pyrimidin-4-yl]acetamide
C9H10N4O2S
Acta Crystallographica Section C (2008) 64, 3 o149-o154
a=17.106(3)Å b=11.8218(13)Å c=13.7187(19)Å
α=90.00° β=127.836(8)° γ=90.00°
3-(5-Chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-1-(4-methoxyphenyl)propenone
C20H17ClN2O2
Acta Crystallographica Section C (2005) 61, 6 o414-o416
a=12.7985(10)Å b=4.0684(3)Å c=16.6766(14)Å
α=90.00° β=95.918(4)° γ=90.00°
3-(5-Chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-1-(3,4,5- trimethoxyphenyl)propenone
C22H21ClN2O4
Acta Crystallographica Section C (2005) 61, 6 o414-o416
a=7.5118(2)Å b=8.8121(3)Å c=15.6709(4)Å
α=81.8250(10)° β=82.750(2)° γ=79.459(2)°
(<i>E</i>)-3-{2-Amino-4-ethoxy-6-[<i>N</i>-(4-methoxyphenyl)-N- methylamino]pyrimidin-5-yl}-1-phenylprop-2-en-1-one
C23H24N4O3
Acta Crystallographica Section C (2007) 63, 12 o758-o760
a=10.1975(14)Å b=10.959(2)Å c=11.046(2)Å
α=94.079(16)° β=109.845(11)° γ=113.339(10)°
Ethyl (E)-3-[2-amino-4,6-bis(dimethylamino)pyrimidin-5-yl]-2-cyanoacrylate
C14H20N6O2
Acta Crystallographica Section C (2008) 64, 3 o145-o148
a=8.5570(15)Å b=9.893(2)Å c=9.9739(18)Å
α=87.534(13)° β=77.251(15)° γ=67.431(14)°
2-[(2-amino-4,6-di-1-piperidylpyrimidin-5-yl)methylene]malononitrile
C18H23N7
Acta Crystallographica Section C (2008) 64, 3 o145-o148
a=9.6960(8)Å b=14.752(3)Å c=15.418(3)Å
α=116.332(13)° β=96.794(10)° γ=93.587(9)°
2-Amino-4-chloro-5-formyl-6-[methyl(2-methylphenyl)amino]pyrimidine
C13H13ClN4O
Acta Crystallographica Section C (2009) 65, 1 o11-o14
a=11.1502(8)Å b=8.7271(8)Å c=13.7129(13)Å
α=90.00° β=105.676(7)° γ=90.00°
2-amino-4-chloro-5-formyl-6-[(2-methoxyphenyl)methylamino]pyrimidine,
C13H13ClN4O2
Acta Crystallographica Section C (2009) 65, 1 o11-o14
a=11.301(4)Å b=8.642(3)Å c=14.568(5)Å
α=90.00° β=111.13(3)° γ=90.00°
10-Benzyl-4-oxo-2,3,4,10-tetrahydropyrimido[4,5-<i>b</i>]quinolin-2-iminium chloride sesquihydrate
C18H15N4O,Cl,1.5(H2O)
Acta Crystallographica Section C (2010) 66, 9 o469-o472
a=18.8725(10)Å b=18.4777(8)Å c=13.417(2)Å
α=90.00° β=134.307(7)° γ=90.00°
Bis(6-amino-3-methyl-2-methylsulfanyl-4-oxopyrimidin-5-yl)methane
C13H18N6O2S2
Acta Crystallographica Section C (2013) 69, 9 1043-1046
a=19.862(6)Å b=7.4877(19)Å c=14.236(5)Å
α=90.00° β=133.61(2)° γ=90.00°
(4-(Pyrrolidin-1-yl)-1/H/-pyrazolo[3,4-/d/]pyrimidin-6-amine) ethanol hemisolvate hemihydrate
2(C9H12N6),C2H6O,H2O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=7.9342(15)Å b=8.9219(19)Å c=16.767(3)Å
α=76.855(16)° β=83.505(14)° γ=88.003(17)°
3-<i>tert</i>-Butyl-7-(4-methoxybenzyl)-4',4'-dimethyl-1-phenyl-4,5,6,7- tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane- 2',6'-dione
C31H37N3O3
Acta Crystallographica Section C (2008) 64, 12 o665-o670
a=9.5971(8)Å b=11.2549(16)Å c=12.1452(14)Å
α=86.979(11)° β=85.487(10)° γ=87.216(7)°